UOC
ADMA icon

UBS O'Connor’s ADMA Biologics ADMA Stock Holding History

UBS O'Connor’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-75,000
Closed -$446K – 416
2016
Q2 		$446K Buy
75,000
+6,323
+9% +$44.3K 0.01% 347
2016
Q1 		$555K Sell
68,677
-4,123
-6% -$23.5K 0.01% 389
2015
Q4 		$590K Hold
72,800
– – 0.01% 382
2015
Q3 		$608K Hold
72,800
– – 0.01% 451
2015
Q2 		$674K Sell
72,800
-9,200
-11% -$79.6K 0.01% 658
2015
Q1 		$804K Buy
+82,000
New +$826K 0.01% 562

Other funds holding ADMA

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

UBS O'Connor's ADMA Position: Q3 2016 in Review

UBS O'Connor sold out of ADMA Biologics (ADMA) in Q3 2016, closing a stake of 75,000 shares — an estimated $446K sold.

UBS O'Connor first reported a position in ADMA in Q1 2015 and held it in 6 quarters. The position peaked at $804K in Q1 2015. 19 funds tracked by Wall St. Rank hold ADMA as of Q3 2016.

  • UBS O'Connor reported no remaining ADMA Biologics position as of Q3 2016 after selling out during the quarter.
  • UBS O'Connor sold 75,000 ADMA Biologics shares in Q3 2016, an estimated $446K.
  • UBS O'Connor first reported a position in ADMA Biologics in Q1 2015 and held it in 6 quarters.
  • UBS O'Connor's ADMA Biologics position peaked at $804K in Q1 2015.
  • 19 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2016.

Based on UBS O'Connor's 13F filing for Q3 2016, filed 14 Nov 2016.